| “Desert” gene (Chr9p21) variants as novel markers for coronary artery disease | Heba A. SHENDY,Sally I HASSANEİN,Mohamed Z GAD | 84–89 |
| The impact of cardiac rhythm on the mitral valve area and gradient in patients with mitral stenosis | Hasan ARI,Selma ARI,Alper KARAKUŞ,Sencer CAMCI,Kübra DOĞANAY,Ahmet TÜTÜNCÜ,Mehmet MELEK,TAHSİN BOZAT | 90–98 |
| Ghrelin expression and significance in 92 patients with atrial fibrillation | Tianyi MA,Yujiang SU,Shijuan LU,Moshui CHEN,Jianghua ZHONG,Zhihong ZHOU,Dingjun SUN,Hui YANG,Xue AO | 99–102 |
| Fluvastatin therapy could not decrease progression of paroxysmal atrial fibrillation in non-valvular disease patients | Qiang TAN,Shuangyue ZHANG,Xiaoyi ZOU,Jun ZHAO,Jia HAO,Qian SUN | 103–107 |
| Surface electrocardiogram: Could atrioventricular nodal and His bundle potentials be recorded beat by beat on “Saah electrocardiogram”? | Qinghua CHANG,Renguang LİU,Juan CHEN | 110–114 |
| Effects of garlic on brachial endothelial function and capacity of plasma to mediate cholesterol efflux in patients with coronary artery disease | Marjan MAHDAVİ-ROSHAN,Parvin MİRMİRAN,Mohammad ARJMAND,Javad NASROLLAHZADEH | 116–121 |
| The role of SCUBE1 in the pathogenesis of no-reflow phenomenon presenting with ST segment elevation myocardial infarction | Hasan Ata BOLAYIR,HAKAN GÜNEŞ,Tarik KIVRAK,Ömer ŞAHİN,Dursun AKASLAN,Recep KURT,ASLI BOLAYIR,Oya İMADOĞLU | 122–127 |
| Previous cerebrovascular disease is an important predictor of clinical outcomes in elderly patients with percutaneous coronary interventions: The Nobori-Biolimus eluting stent prospective multicenter 1-year observational registry in South Korea | Yong Hoon KİM,Ae-Youngr HER,Byeong-Keuk KİM,Dong-Ho SHİN,Jung-sun KİM,Young-Guk KO,Donghoon CHOI,Myeong-Ki HONG,Yangsoo JANG | 128–135 |
| Clinical impact and efficacy of bedside echocardiography on patient management in pediatric intensive care units (PICUs): A prospective study | Şanlıay ŞAHİN,Mutlu Uysal YAZICI,Ganime AYAR,Tülin KÖKSAL,İBRAHİM İLKER ÇETİN,FİLİZ EKİCİ,ABDULLAH KOCABAŞ | 136–141 |
| Vagal denervation in atrial fibrillation ablation: A comprehensive review |